CPDC Board Approves Xiaogang Plant CPL Line Shutdown Amid Oversupply

Key Takeaways

  • China Petrochemical Development Corporation (CPDC) board approved shutdown and decommissioning of Xiaogang plant CPL line on 115/11/12.
  • China Petrochemical Development Corporation (CPDC) disclosed its CPL line accounted for 14.33% of consolidated revenue in year 114.
  • China Petrochemical Development Corporation (CPDC) stated the shutdown eliminates ongoing losses from the CPL product line.

China Petrochemical Development Corporation (CPDC, stock code 1314) board of directors approved on 115/11/12 the shutdown and decommissioning of the Caprolactam (CPL) production line at its Xiaogang plant. The decision follows global CPL overcapacity, US trade and tariff policy shifts, and geopolitical factors including the Russia-Ukraine war and US-Iran conflicts, which have driven continued contraction in Taiwan's CPL demand. CPDC stated the production line no longer holds economic viability for continued operation and will redirect resources toward high-value chemical production to enhance operational efficiency and long-term shareholder value.

Xiaogang Plant CPL Production Capacity and Output Data

The Xiaogang plant CPL production line maintained a capacity of 200,000 tons per year across the most recent three fiscal years. Actual production output was 146,883 tons in year 112, 155,765 tons in year 113, and 99,546 tons in year 114. For year 115 through the third quarter, output totaled 44,631 tons before the shutdown decision.

CPL Line Revenue Impact on CPDC Consolidated Financials

The CPL production line accounted for 14.33% of CPDC's consolidated revenue in year 114 and 17.93% of consolidated revenue through the third quarter of year 115. CPDC stated in the regulatory filing that while the shutdown reduces a portion of revenue, it eliminates ongoing losses from the product line and improves overall operational efficiency.

Board Approval Process for Production Line Shutdown

The board of directors reviewed and approved the shutdown and decommissioning plan during the 115/11/12 meeting. CPDC cited the management team's evaluation of the product's continued competitiveness, concluding that limited prospects for market recovery justified ceasing operations to reduce operational risk and prevent further resource depletion.

FAQ

What did CPDC announce on 115/11/12?
CPDC board of directors approved the shutdown and decommissioning of the Caprolactam production line at the Xiaogang plant on 115/11/12.

Why did CPDC decide to shut down the CPL production line?
CPDC cited global CPL overcapacity, US trade and tariff policy changes, geopolitical factors including the Russia-Ukraine war and US-Iran conflicts, and continued contraction in Taiwan CPL demand as reasons the production line no longer holds economic viability.

What was the CPL line's revenue contribution to CPDC?
The CPL production line accounted for 14.33% of CPDC's consolidated revenue in year 114 and 17.93% through the third quarter of year 115.

Disclaimer: This content is for informational purposes only and does not constitute investment advice or encourage the buying or selling of crypto assets. It is intended to provide information about industry developments and is not directly related to the services offered by Gate TR. Although information obtained from third-party sources has been carefully reviewed, Gate TR assumes no responsibility for any errors or omissions. Crypto assets involve high risks and may experience significant price fluctuations. Before making any investment decisions, you should assess your financial situation and risk tolerance, conduct your own research, and make decisions independently.